LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness.
I. Pallavicini, T. M. Frasconi, E. Ceccaci, S. Tiberti, C. B. Nava Lauson, E. Preto, A. O. Bigogno, M. Mangione, E. Sala, M. Iannacone, M. Kuka, L. Nezi, S. Minucci, T. Manzo
This study shows that inhibiting LSD1 enhances CD8+ T cell function in adoptive T cell therapy, leading to improved antitumor immunity and synergistic effects with anti-PDL1 therapy.
bioRxiv · Oct 27, 2023Immunology